Top

Published in:

01-04-2014 | Meeting report

Meeting report on the Alzheimer’s Drug Discovery Foundation 14th International Conference on Alzheimer’s Drug Discovery

Authors: Lauren G Friedman, Katherine Price, Rachel F Lane, Aaron J Carman, Penny A Dacks, Diana W Shineman, Howard M Fillit

Published in: Alzheimer's Research & Therapy | Issue 2/2014

Abstract

The Alzheimer’s Drug Discovery Foundation’s 14th International Conference on Alzheimer’s Drug Discovery was held on 9 and 10 September in Jersey City, NJ, USA. This annual meeting highlights novel therapeutic approaches supported by the Alzheimer’s Drug Discovery Foundation in development for Alzheimer’s disease and related dementias.

Sanz JM, Chiozzi P, Ferrari D, Colaianna M, Idzko M, Falzoni S, Fellin R, Trabace L, Di VF: Activation of microglia by amyloid β requires P2X7 receptor expression. J Immunol. 2009, 182: 4378-4385. 10.4049/jimmunol.0803612.CrossRefPubMed

Min SW, Cho SH, Zhou Y, Schroeder S, Haroutunian V, Seeley WW, Huang EJ, Shen Y, Masliah E, Mukherjee C, Meyers D, Cole PA, Ott M, Gan L: Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron. 2010, 67: 953-966. 10.1016/j.neuron.2010.08.044.PubMedCentralCrossRefPubMed

15th International Conference on Alzheimer’s Drug Discovery.http://www.worldeventsforum.com/addf/addrugdiscovery/,

ADDF Scientific Conferences.http://www.alzdiscovery.org/events/conferences,

Title: Meeting report on the Alzheimer’s Drug Discovery Foundation 14th International Conference on Alzheimer’s Drug Discovery
Authors: Lauren G Friedman
Katherine Price
Rachel F Lane
Aaron J Carman
Penny A Dacks
Diana W Shineman
Howard M Fillit
Publication date: 01-04-2014
Publisher: BioMed Central
Published in: Alzheimer's Research & Therapy / Issue 2/2014
Electronic ISSN: 1758-9193
DOI: https://doi.org/10.1186/alzrt252

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Meeting report on the Alzheimer’s Drug Discovery Foundation 14th International Conference on Alzheimer’s Drug Discovery

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2014

Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels

Roadblocks for integration of novel biomarker concepts into clinical routine: the peptoid approach

Lewy body dementia: the impact on patients and caregivers

Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer’s disease: a phase I study

Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β

Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease